MTHFR Gene Polymorphisms Prevalence and Cardiovascular Risk Factors Involved in Cardioembolic Stroke Type and Severity

Figure 1. Patients with C677T mutation have a higher risk for developing higher DBP values (odds ratio (OR) = 1.881, 95%CI = (1.804, 4.964)).

Figure 2. Patients with MTHFR C677T mutation have a high risk for increased HbA1c values (OR = 1.982, 95%CI = (1.171, 7.799)).

Figure 3. C677T mutation in the MTHFR gene is associated with a high risk for hypertrygliceridemia (OR = 1.392, 95%CI = (1.192, 3.994)).

Figure 4. MTHFR A1298C is associated with a risk for high triglycerides (TGL) values (OR = 2.983, 95%CI = (1.972, 7.994)).

Figure 5. Percentage of patients on acenocumarol vs. NOAC.

Figure 6. Association between cardioembolic stroke localization and MTHFR polymorphism by applying Chi2 Test.

Figure 7. Association between previous lacunar stroke and MTHFR polymorphisms using Chi2 Test.

Figure 8. Association between recurrent stroke and MTHFR polymorphisms by Chi2 Test.

Figure 9. Comparison of NIHSS scores between patients without vs. with one or both MTHFR polymorphisms.

Figure 10. Comparison between patients without vs. with one or both polymorphisms of the MTHFR gene regarding mRS scores.